Jason P Rhodes
CIK 1577014 · President, CFO and Treasurer · last filed 2026-07-08
Jason P Rhodes is a President, CFO and Treasurer who has filed 53 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing shows the insider sold $17.9M of DYN on Jul 8, 2026. Across all open-market trades the lifetime net is −$108.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.99M
5
53
-$108.75M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Director | 2,962 | $26.71 | $79.1K | -$83.28M | 19 | 2026-07-08 |
| Generation Bio Co. (GBIO) Delisted | Director | 0 | $5.34 | $0 | -$18.24M | 14 | 2026-02-09 |
| REPL | Director | 946,000 | $13.65 | $12.91M | -$2.69M | 11 | 2022-04-05 |
| Disc Medicine, Inc. (GMTX) Delisted | Director | — | $13.50 | — | $0 | 1 | 2021-10-06 |
| Epizyme, Inc. (EPZM) Delisted | President, CFO and Treasurer | 138,000 | $1.47 | $202.9K | -$4.54M | 8 | 2014-09-24 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-08 | DYN | Sell (S) | −777,451 | -$17.86M | EDGAR |
| 2026-06-26 | DYN | Sell (S) | −267,760 | -$5.65M | EDGAR |
| 2026-06-09 | DYN | Grant (A) | — | $0 | EDGAR |
| 2026-05-06 | DYN | Sell (S) | −106,723 | -$1.94M | EDGAR |
| 2026-04-27 | DYN | Sell (S) | −384,549 | -$7.10M | EDGAR |
| 2026-04-22 | DYN | Sell (S) | −834,302 | -$16.48M | EDGAR |
| 2026-02-09 | Generation Bio Co. (GBIO) Delisted | Mixed | −827,946 | $0 | EDGAR |
| 2025-06-06 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | DYN | Grant (A) | — | $0 | EDGAR |
| 2025-01-29 | DYN | Grant (A) | +1,111,111 | $15.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.